Literature DB >> 4812616

Inhibitory effect of dopaminergic stimulation on GH release in acromegaly.

P G Chiodini, A Liuzzi, L Botalla, G Cremascoli, F Silvestrini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4812616     DOI： 10.1210/jcem-38-2-200

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  8 in total

Review 1.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

Review 2.  Cabergoline in acromegaly.

Authors:  Emmanuelle Kuhn; Philippe Chanson
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 3.  The role of combination medical therapy in the treatment of acromegaly.

Authors:  Dawn Shao Ting Lim; Maria Fleseriu
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

4.  Pituitary function and growth hormone dynamics in acromegaloidism.

Authors:  R B Mims
Journal:  J Natl Med Assoc       Date:  1978-12       Impact factor: 1.798

5.  Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy.

Authors:  J Balldin; A K Granérus; G Lindstedt; K Modigh; J Wålinder
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 6.  Pharmacological therapy for acromegaly: a critical review.

Authors:  Alex F Muller; Aart Jan Van Der Lely
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Recent developments in acromegaly: a review.

Authors:  A Jadresic
Journal:  J R Soc Med       Date:  1983-11       Impact factor: 18.000

Review 8.  Pasireotide in the Personalized Treatment of Acromegaly.

Authors:  Manel Puig-Domingo; Ignacio Bernabéu; Antonio Picó; Betina Biagetti; Joan Gil; Cristina Alvarez-Escolá; Mireia Jordà; Montserrat Marques-Pamies; Berta Soldevila; María-Angeles Gálvez; Rosa Cámara; Javier Aller; Cristina Lamas; Mónica Marazuela
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-16       Impact factor: 5.555
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.